Overcoming Challenges & the Role of PKPD in the Development of Ocular Complement Therapy
4:30 pm - Wednesday 9th December 2026
- Evaluating how novel ocular delivery approaches can overcome barriers to targeting complement pathways in retinal disease
- Leveraging PK/PD insights to optimize therapeutic exposure, dosing strategies, and clinical outcomes in ophthalmology
- Advancing complement and gene therapy approaches for AMD and other neurodegenerative eye diseases through targeted drug delivery
NEW SPEAKING COMPANY
